PL2918267T3 - Kompozycja farmaceutyczna w postaci cząstek stałych - Google Patents

Kompozycja farmaceutyczna w postaci cząstek stałych

Info

Publication number
PL2918267T3
PL2918267T3 PL15159795T PL15159795T PL2918267T3 PL 2918267 T3 PL2918267 T3 PL 2918267T3 PL 15159795 T PL15159795 T PL 15159795T PL 15159795 T PL15159795 T PL 15159795T PL 2918267 T3 PL2918267 T3 PL 2918267T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
particulate pharmaceutical
particulate
composition
pharmaceutical
Prior art date
Application number
PL15159795T
Other languages
English (en)
Inventor
Atsushi Ishii
Yasuki Kato
Original Assignee
Nanocarrier Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanocarrier Co., Ltd. filed Critical Nanocarrier Co., Ltd.
Publication of PL2918267T3 publication Critical patent/PL2918267T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15159795T 2010-02-12 2011-02-14 Kompozycja farmaceutyczna w postaci cząstek stałych PL2918267T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010029486A JP4653242B1 (ja) 2010-02-12 2010-02-12 粒子状医薬組成物

Publications (1)

Publication Number Publication Date
PL2918267T3 true PL2918267T3 (pl) 2017-09-29

Family

ID=43952737

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11711242T PL2415463T3 (pl) 2010-02-12 2011-02-14 Kompozycja lecznicza w postaci cząstek stałych
PL15159795T PL2918267T3 (pl) 2010-02-12 2011-02-14 Kompozycja farmaceutyczna w postaci cząstek stałych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL11711242T PL2415463T3 (pl) 2010-02-12 2011-02-14 Kompozycja lecznicza w postaci cząstek stałych

Country Status (12)

Country Link
US (2) US9198860B2 (pl)
EP (2) EP2918267B1 (pl)
JP (1) JP4653242B1 (pl)
KR (2) KR101839545B1 (pl)
CN (1) CN102753151B (pl)
AU (1) AU2011215177B2 (pl)
CA (1) CA2785858C (pl)
DK (2) DK2415463T3 (pl)
ES (2) ES2560810T3 (pl)
PL (2) PL2415463T3 (pl)
PT (2) PT2415463E (pl)
WO (1) WO2011099601A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9808480B2 (en) 2012-04-27 2017-11-07 Nanocarrier Co., Ltd. Unit structure-type pharmaceutical composition for nucleic acid delivery
US20180015007A1 (en) * 2015-02-27 2018-01-18 Nanocarrier Co., Ltd. Polymeric micelle carrier composition and polymeric micelle composition
EP3677268A4 (en) 2017-08-31 2021-04-21 The University Of Tokyo UNIFORM POLYIONAL COMPLEX LOADED WITH NUCLEIC ACID
JP2024501974A (ja) * 2020-12-28 2024-01-17 公益財団法人川崎市産業振興財団 ポリイオンコンプレックスミセル

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02121932A (ja) * 1988-10-29 1990-05-09 Res Inst For Prod Dev ヘモグロビン含有リポソーム、その製造方法および該製造方法用の原液
KR940003548U (ko) 1992-08-14 1994-02-21 김형술 세탁물 건조기
US6884430B1 (en) 1997-02-10 2005-04-26 Aventis Pharma S.A. Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
FR2759298B1 (fr) 1997-02-10 1999-04-09 Rhone Poulenc Rorer Sa Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
ES2212305T3 (es) 1997-06-23 2004-07-16 Alza Corporation Polinucleotidos encapsulados en liposomas, composicion y procedimiento.
AU742250B2 (en) 1997-12-26 2001-12-20 Astellas Pharma Inc. Sustained release medicinal compositions
JP2000302685A (ja) * 1999-02-18 2000-10-31 Sankyo Co Ltd 抗腫瘍薬含有リポソーム製剤
DE19954843C2 (de) 1999-11-09 2003-11-20 Novosom Ag Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung
JP3942362B2 (ja) * 2000-02-02 2007-07-11 アンジェスMg株式会社 遺伝子導入のためのウイルスエンベロープベクター
TWI303663B (en) 2000-02-02 2008-12-01 Kaneda Yasufumi Inactivated virus envelope
FR2814951B1 (fr) 2000-10-06 2003-01-17 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation
EP1415648B1 (en) 2001-07-13 2006-11-22 NanoCarrier Co., Ltd. Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
JP4063510B2 (ja) * 2001-07-13 2008-03-19 ナノキャリア株式会社 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤
JP4294946B2 (ja) * 2002-12-13 2009-07-15 富士フイルム株式会社 標的検出装置及び標的検出方法並びに標的検出用基材
CA2508279A1 (en) 2002-12-23 2004-07-22 Vical Incorporated Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes
JPWO2005092389A1 (ja) 2004-03-10 2007-08-16 協和醗酵工業株式会社 複合粒子および被覆複合粒子
EP1773857A4 (en) * 2004-07-02 2009-05-13 Protiva Biotherapeutics Inc THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
WO2006060723A2 (en) * 2004-12-03 2006-06-08 Vical Incorporated Methods for producing block copolymer/amphiphilic particles
WO2007043486A1 (ja) * 2005-10-05 2007-04-19 Tokyo Cro, Inc. 生体適合性ブロック共重合体、その用途および製造法
JP2006321763A (ja) * 2005-05-20 2006-11-30 Hosokawa Funtai Gijutsu Kenkyusho:Kk 生体適合性ナノ粒子及びその製造方法
JP2007099631A (ja) 2005-09-30 2007-04-19 Hosokawa Funtai Gijutsu Kenkyusho:Kk アニオン性薬物封入ナノ粒子の製造方法及びそれを用いた医薬製剤
WO2007136134A1 (ja) * 2006-05-23 2007-11-29 Nanocarrier Co., Ltd. 疎水性薬物内包ポリマーミセルの製造方法
CA2658082C (en) 2006-07-18 2015-03-17 Nanocarrier Co., Ltd. Physiologically active polypeptide- or protein-encapsulating polymer micelles, and method for production of the same
WO2008109105A2 (en) * 2007-03-06 2008-09-12 Flagship Ventures Methods and compositions for improved therapeutic effects with sirna
JP2009200681A (ja) 2008-02-20 2009-09-03 Seiko Instruments Inc 近接検出装置および近接検出方法
CA2748520C (en) * 2008-12-26 2013-12-17 Se-Ho Kim Pharmaceutical composition containing an anionic drug, and a production method therefor

Also Published As

Publication number Publication date
EP2415463A4 (en) 2012-02-29
CA2785858A1 (en) 2011-08-18
ES2636778T3 (es) 2017-10-09
US20120076866A1 (en) 2012-03-29
PT2918267T (pt) 2017-06-22
KR20120113754A (ko) 2012-10-15
AU2011215177A1 (en) 2012-07-05
US9198860B2 (en) 2015-12-01
KR101839545B1 (ko) 2018-03-16
CN102753151A (zh) 2012-10-24
CA2785858C (en) 2016-04-26
PL2415463T3 (pl) 2016-06-30
EP2415463A1 (en) 2012-02-08
DK2415463T3 (en) 2016-04-11
US9795563B2 (en) 2017-10-24
PT2415463E (pt) 2016-03-22
JP4653242B1 (ja) 2011-03-16
US20160058703A1 (en) 2016-03-03
EP2415463B1 (en) 2016-01-13
KR20160041057A (ko) 2016-04-15
JP2011162512A (ja) 2011-08-25
DK2918267T3 (en) 2017-07-10
WO2011099601A1 (ja) 2011-08-18
ES2560810T3 (es) 2016-02-22
KR101612876B1 (ko) 2016-04-18
AU2011215177B2 (en) 2015-10-15
EP2918267B1 (en) 2017-05-10
EP2918267A1 (en) 2015-09-16
CN102753151B (zh) 2014-08-06

Similar Documents

Publication Publication Date Title
IL245326B (en) pharmaceutical preparation
PL2619182T3 (pl) Kompozycja farmaceutyczna
IL223535A (en) Solid medicinal compositions
ZA201300458B (en) C-met-modulator pharmaceutical compositions
IL225457A0 (en) Pharmaceutical composition
ZA201301766B (en) Pharmaceutical compositions
ZA201207670B (en) Pharmaceutical compositions
HUE050788T2 (hu) Új gyógyászati kompozíció
ZA201300718B (en) Pharmaceutical compositions
PT2579858E (pt) Composição farmacêutica que contém ivabradina
ZA201301920B (en) Pharmaceutical composition
GB201010453D0 (en) Pharmaceutical composition
ZA201303223B (en) Pharmaceutical compositions
ZA201303177B (en) Pharmaceutical compositions
PT2918267T (pt) Composições farmacêuticas em partículas
IL221501A (en) Medicinal product containing miramistine
EP2560678A4 (en) PHARMACEUTICAL COMPOSITIONS
GB201001911D0 (en) Pharmaceutical composition
PL2534235T3 (pl) Kompozycja
GB201019775D0 (en) Pharmaceutical composition
HU1000006D0 (en) Improved pharmaceutical composition
ZA201303732B (en) Pharmaceutical compositions
GB201008590D0 (en) Pharmaceutical compositions